Globus Medical (GMED)
Builds spine and orthopedic systems spanning implants, robotics, navigation, and pain therapies.
$74.09
vs last close−1.10 (−1.46%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 384 | 617 | 607 | 630 | 626 | 657 | 598 | 745 | 769 | 826 | 760 | 790 |
| Cost of revenue | 135 | 265 | 241 | 260 | 271 | 263 | 195 | 249 | 282 | 231 | 234 | 241 |
| Gross profit | 248 | 351 | 365 | 370 | 355 | 394 | 403 | 497 | 487 | 595 | 526 | 548 |
| 248 | 341 | 357 | 320 | 307 | 334 | 306 | 420 | 352 | 423 | 364 | 366 | |
| Research & development | 29 | 52 | 57 | 38 | 35 | 33 | 33 | 40 | 38 | 74 | 37 | 36 |
| Selling, general & administrative | 156 | 245 | 249 | 239 | 241 | 253 | 243 | 304 | 314 | 456 | 298 | 287 |
| Other expenses | 62 | 44 | 51 | 43 | 31 | 47 | 30 | 77 | 0 | −107 | 30 | 43 |
| Operating income | 0 | 10 | 8 | 50 | 48 | 60 | 97 | 76 | 135 | 172 | 164 | 182 |
| 2 | 15 | −17 | −2 | 9 | −36 | 7 | 112 | 9 | 2 | −6 | 7 | |
| Interest income | 8 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 3 | 5 | 0 |
| Interest expense | 0 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | −49 | −16 | −22 | −13 | −1 | −17 | −1 | −47 | −9 | −2 | 6 | −7 |
| Income before tax | 3 | 25 | −9 | 48 | 57 | 25 | 104 | 188 | 144 | 174 | 157 | 190 |
| Income tax expense | 2 | 10 | −1 | 16 | 5 | −2 | 28 | −15 | 25 | 33 | 33 | 38 |
| Net income from continuing operations | 1 | 15 | −7 | 32 | 52 | 27 | 75 | 203 | 119 | 141 | 124 | 152 |
| Net income | 1 | 15 | −7 | 32 | 52 | 27 | 75 | 203 | 119 | 141 | 124 | 152 |
| EPS, basic | $0.01 | $0.11 | −$0.05 | $0.23 | $0.38 | $0.19 | $0.55 | $1.50 | $0.88 | $1.05 | $0.92 | $1.12 |
| EPS, diluted | $0.01 | $0.11 | −$0.05 | $0.23 | $0.38 | $0.19 | $0.54 | $1.49 | $0.88 | $1.01 | $0.90 | $1.10 |
| Weighted average shares, basic | 114 | 138 | 135 | 135 | 136 | 137 | 137 | 135 | 135 | 135 | 135 | 135 |
| Weighted average shares, diluted | 115 | 139 | 135 | 137 | 138 | 140 | 140 | 136 | 135 | 137 | 138 | 138 |
| EBITDA | 86 | 97 | 85 | 126 | 116 | 145 | 164 | 193 | 215 | 244 | 227 | 190 |
| Depreciation & amortization | 37 | 71 | 55 | 64 | 67 | 68 | 66 | 71 | 71 | 70 | 70 | 0 |
| EBIT | 49 | 26 | 30 | 63 | 49 | 77 | 98 | 123 | 144 | 174 | 157 | 190 |